Skip to main content
. 2022 May 2;22:481. doi: 10.1186/s12885-022-09621-1

Fig. 5.

Fig. 5

PB lnc-LOC as a potential MRD monitoring marker for APL patients. a PB lnc-LOC levels were positively correlated with PML-RARα transcript expression in APL patients at diagnosis (R2 = 0.949, P < 0.001*). b PB lnc-LOC levels were positively correlated with PML-RARα transcript expression in APL patients postinduction (R2 = 0.934, P < 0.001*). c PB lnc-LOC levels were consistently correlated with MRD values in APL patients postinduction (R2 = 0.904, P < 0.001*). * Statistically significant